Connect AccountAll persons who purchased or acquired FibroGen securities, including options, between December 20, 2018 through July 15, 2021, inclusive.
Preliminarily Approved
December 19, 2018 - October 13, 2021
May 16, 2024
April 18, 2024
JND Legal Administration
In re FibroGen, Inc. Securities Litigationc/o JND Legal AdministrationP.O. Box 91482Seattle, WA 98111
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.